← FDA DRUG APPROVALS

FDA ANDA · ANDA074971

KETOCONAZOLE

Sponsor: CHARTWELL RX

APPLICATION
ANDA074971
TYPE
ANDA
ORIGINAL APPROVAL
1999-06-15
LATEST ACTION
2023-08-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

KETOCONAZOLEDiscontinued
KETOCONAZOLE 200MG · TABLET · ORAL

Approval history

2023-08-16Labeling · Supplement 5 · standardAP
2023-08-01Labeling · Supplement 4 · standardAP
2020-02-18Labeling · Supplement 3 · standardAP
2017-11-15Labeling · Supplement 2 · standardAP
1999-06-15OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →